“Aren’t women’s sexual needs as important as erectile dysfunction in men?” To hear one side tell it, that’s the central issue in the debate over what’s known as “pink Viagra,” a sexual-dysfunction drug for women. Health organizations and the pharmaceutical industry say the absence of a female drug is a pressing problem that affects millions of relationships in the U.S.